Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) Trial

This is a preview of subscription content, log in to check access.


  1. 1.

    Pilewskie M, Stemple M, Rosenfeld H, et al. Do LORIS trial eligibility criteria identify a ductal carcinoma in situ patient population at low risk of upgrade to invasive carcinoma. Ann Surg Oncol. 2016;23:3487–93.

    Article  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Francis A, Thomas J, Fallowfield L, et al. Addressing overtreatment of screen detected DCIS; the LORIS trial. Eur J Cancer. 2015;51:2296–303.

    Article  PubMed  Google Scholar 

  3. 3.

  4. 4.

    Wells WA, Carney PA, Eliasson MS, Grove MR, Tosteson ANA. Pathologists’ agreement with experts and reproducibility of breast ductal carcinoma in situ classification schemes. Am J Surg Pathol. 2000;24:651–9.

    Article  PubMed  CAS  Google Scholar 

  5. 5.

    Schuh F, Biazus JV, Resetkova E, Benfica CZ, Edelweiss MIA. Reproducibility of three classification systems of ductal carcinoma in situ of the breast using a web-based survey. Pathol Res Pract. 2010;206:705–11.

    Article  PubMed  Google Scholar 

  6. 6.

    Douglas-Jones A, Morgan JM, Appleton MAC, et al. Consistency in the observation of features used to classify duct carcinoma in situ (DCIS) of the breast. J Clin Pathol. 2000;53:596–602.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. 7.

    Kim J, Han W, Lee JW, et al. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision. Breast. 2012;21:641–5.

    Article  PubMed  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Daniel Rea BSc, MBBS, PhD, FRCP.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Rea, D., Francis, A., Wallis, M. et al. Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) Trial. Ann Surg Oncol 24, 566–567 (2017).

Download citation